1. Home
  2. NRXP vs SCWO Comparison

NRXP vs SCWO Comparison

Compare NRXP & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SCWO
  • Stock Information
  • Founded
  • NRXP 2015
  • SCWO 2021
  • Country
  • NRXP United States
  • SCWO United States
  • Employees
  • NRXP N/A
  • SCWO N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • NRXP Health Care
  • SCWO Utilities
  • Exchange
  • NRXP Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • NRXP 34.7M
  • SCWO 39.9M
  • IPO Year
  • NRXP N/A
  • SCWO N/A
  • Fundamental
  • Price
  • NRXP $1.98
  • SCWO $0.28
  • Analyst Decision
  • NRXP Strong Buy
  • SCWO
  • Analyst Count
  • NRXP 4
  • SCWO 0
  • Target Price
  • NRXP $28.25
  • SCWO N/A
  • AVG Volume (30 Days)
  • NRXP 128.2K
  • SCWO 287.5K
  • Earning Date
  • NRXP 05-13-2025
  • SCWO 05-14-2025
  • Dividend Yield
  • NRXP N/A
  • SCWO N/A
  • EPS Growth
  • NRXP N/A
  • SCWO N/A
  • EPS
  • NRXP N/A
  • SCWO N/A
  • Revenue
  • NRXP N/A
  • SCWO $445,445.00
  • Revenue This Year
  • NRXP N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • NRXP N/A
  • SCWO $106.82
  • P/E Ratio
  • NRXP N/A
  • SCWO N/A
  • Revenue Growth
  • NRXP N/A
  • SCWO N/A
  • 52 Week Low
  • NRXP $1.10
  • SCWO $0.25
  • 52 Week High
  • NRXP $6.01
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 48.76
  • SCWO 45.06
  • Support Level
  • NRXP $1.85
  • SCWO $0.33
  • Resistance Level
  • NRXP $1.97
  • SCWO $0.30
  • Average True Range (ATR)
  • NRXP 0.16
  • SCWO 0.03
  • MACD
  • NRXP 0.03
  • SCWO 0.00
  • Stochastic Oscillator
  • NRXP 71.43
  • SCWO 36.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: